Orencia for Arthritis
Links shared publicly online about this topic
Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
empr.com — “The FDA has approved a subcutaneous formulation of Orencia (abatacept; Bristol-Myers Squibb) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on August 1, 2011 at 2:49 pm By:
MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58
Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis
medicalnewstoday.com — “Sermo, the world's largest online community for physicians, announced a Sermo Event Report titled Is there any Threat to Anti-TNFs from Newer Biologic DMARDs? In the past year, the FDA has appro” View full resource at medicalnewstoday.com
Most Recently Shared on April 2, 2010 at 2:06 pm By:
MNT Arthritis News Health News
Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis http://mnt.to/3zL8 #arthritis
Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis
news-medical.net — “Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.” View full resource at news-medical.net
Most Recently Shared on October 22, 2009 at 4:16 am By:
Lung Cancer News: Clinical data supports continued development of ORENCIA administration for r.. http://digg.com/u1EoVC
Bristol-Myers Says ORENCIA Trial Positive for Rheumatoid Arthritis Treatment
emaxhealth.com — “Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation of the joints and surrounding tissue causing joint damage and chronic pa...” View full resource at emaxhealth.com
Most Recently Shared on August 28, 2011 at 7:49 pm By:
@dsymons Yes, that "20% improvement = success" is part of the problem. Ex here para 4: http://t.co/t9NPdmr #rheum
Dual Sport Life: Good News, Orencia Is Working « Rheumatoid Arthritis Guy
rheumatoidarthritisguy.com — “Dual Sport Life: Good News, Orencia Is Working « Rheumatoid Arthritis Guy” View full resource at rheumatoidarthritisguy.com
Most Recently Shared on October 23, 2009 at 2:11 pm By:
Dual Sport Life: Good News, Orencia Is Working http://bit.ly/4s3FcJ
Reliable Sources: Orencia Cough Side Effect & Notions of e-Patients | Reality Check | Rheumatoid Arthritis Warrior
rawarrior.com — “If I cited a percentage of patients who get a cough from Orencia, then I--™d quote a source -- probably a clinical trial. However, if I merely say, as a...” View full resource at rawarrior.com
Most Recently Shared on March 22, 2011 at 10:00 am By:
Good morning! Today's blog is not just on side effects. It's also about whether what we say here is valid. One... http://fb.me/XWbq7GDJ
NICE says no to BMS for second-line Orencia | InPharm
inpharm.com — “In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have failed” View full resource at inpharm.com
Most Recently Shared on August 25, 2011 at 11:35 am By:
Pharmafocus Pharma and Health News
NICE says no to BMS for second-line Orencia http://ow.ly/6cnhz #nice #arthritis
Orencia wins expanded European licence | InPharm
inpharm.com — “Orencia wins expanded European licence | InPharm” View full resource at inpharm.com
Most Recently Shared on January 27, 2010 at 1:43 pm By:
Pharmafocus Pharma and Health News
Orencia wins expanded European licence. Bristol-Myers Squibb’s drug can now be used to treat juvenile arthritis. http://ow.ly/10VI5
Article > NICE final "no" for BM-S' Orencia in RA
pharmatimes.com — “Article > NICE final "no" for BM-S' Orencia in RA” View full resource at pharmatimes.com
Most Recently Shared on August 25, 2011 at 12:30 pm By:
Bristol-Myers Squibb's RA drug Orencia got the final thumbs down from U.K. cost-effectiveness agency. http://t.co/JFs85MD $BMY
European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis - Drugs.com MedNews
drugs.com — “European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment o” View full resource at drugs.com
Most Recently Shared on July 8, 2010 at 10:40 am By:
European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after... http://bit.ly/annWwg
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:27 am By:
FDA Approves Subcutaneous Formulation of Orencia - http://bit.ly/pjN8oc
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:14 am By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-A... http://bit.ly/qnjY9u #drug
Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuard
mediguard.org — “Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on May 10, 2011 at 8:17 pm By:
MediGuard.org Health Organization
94% of patients taking #orencia use it for Rheumatoid Arthritis ... http://tinyurl.com/4rkjozx
Rheumatoid Arthritis - Biologic Medications for Rheumatoid Arthritis: Cimzia vs. Simponi
healthcentral.com — “With nine biologic medications available to treat rheumatoid arthritis, it can be difficult knowing which to choose and how they compare. Read my previous...” View full resource at healthcentral.com
Most Recently Shared on May 3, 2010 at 2:34 pm By:
Biologic Medications for RA: Cimzia vs. Simponi - With nine biologic medications available to treat rheumatoid arth... http://ow.ly/17fDbf
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy
medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
MNT Arthritis News Health News
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MNT Arthritis News
The latest arthritis / rheumatology news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Lung Cancer news and research via News-Medical.Net
Advertisement
